BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19715927)

  • 1. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.
    Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos
    Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Cofán F; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2254-5. PubMed ID: 17889155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
    Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.
    Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G
    Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet.
    Apostolou T; Kollia K; Damianou L; Kaitsioti H; Kotsiev V; Dracopoulos S; Vougas V; Hadjiconstantinou V
    Transplant Proc; 2006 Dec; 38(10):3514-6. PubMed ID: 17175318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
    Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
    Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
    López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
    Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.
    Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP
    Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.
    Torregrosa JV; Morales E; Díaz JM; Crespo J; Bravo J; Gómez G; Gentil MÁ; Rodríguez Benot A; García MR; Jiménez VL; Gutiérrez Dalmau A; Jimeno L; Sáez MJ; Romero R; Gómez Alamillo C;
    Nephrology (Carlton); 2014 Feb; 19(2):84-93. PubMed ID: 24428216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
    Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
    Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report.
    Maass E; Mueller GA; Heller T; Koziolek MJ
    Transplant Proc; 2007 Dec; 39(10):3468-70. PubMed ID: 18089410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcimimetics and bone mineral density in renal transplant patients with persistent secondary hyperparathyroidism.
    Toro Prieto FJ; Bernal Blanco G; Navarro García M; Cabello Chaves V; Garcíajiménez R; Pereira Palomo P; Gentil Govantes MA
    Transplant Proc; 2009; 41(6):2144-7. PubMed ID: 19715857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
    Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
    Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.
    Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P
    Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in hypercalcemia with cinacalcet after kidney transplantation.
    Srinivas TR; Schold JD; Womer KL; Kaplan B; Howard RJ; Bucci CM; Meier-Kriesche HU
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):323-6. PubMed ID: 17699223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism.
    Zitt E; Woess E; Mayer G; Lhotta K
    Transplantation; 2011 Oct; 92(8):883-9. PubMed ID: 21876476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.
    Kamar N; Gennero I; Spataru L; Esposito L; Guitard J; Lavayssière L; Cointault O; Gandia P; Durand D; Rostaing L
    Nephrol Dial Transplant; 2008 Nov; 23(11):3720-6. PubMed ID: 18558623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.